Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

CRYM Gene Deafness, Autosomal Dominant Type 40 Genetic Test in UAE | 2800 AED | DHA Certified

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection. Available daily from 8 AM to 11 PM.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The CRYM genetic test uses advanced Next-Generation Sequencing (NGS) to identify pathogenic variants in the CRYM gene responsible for autosomal dominant non-syndromic hearing loss (DFNA40). This comprehensive analysis covers all coding exons and adjacent splice sites, delivering clinically actionable results for families affected by hereditary deafness.

Feature Our Test (CRYM NGS) Closest Alternative (Sanger Sequencing)
Precision >99.9% Analytical Sensitivity & Specificity ~99% for targeted regions
Method Next-Generation Sequencing (NGS) Chain-termination (Sanger) sequencing
Speed 3โ€“4 Weeks 6โ€“8 Weeks
Gene Coverage Full coding region + splice sites Limited to a few exons

Physician Insight & Safety Protocols

โ€œAs a consultant medical geneticist, I emphasize that CRYM test results must always be correlated with a full audiological examination and detailed family history. This molecular diagnosis empowers families with precise risk assessment and reproductive options, but hearing rehabilitation requires multidisciplinary coordination. I urge patients to continue all prescribed hearing management until the full clinical picture is discussed with their specialist.โ€
โ€” Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Clinical Advisory

Important: Genetic test results should not replace immediate clinical evaluation. Always consult your physician for comprehensive management of hearing loss. Do not modify or discontinue any prescribed treatment based solely on genetic findings without specialist guidance.

Safety Exclusion Criteria

  • Recent blood transfusion (within 3 weeks) or allogeneic bone marrow transplant: May interfere with DNA analysis.
  • Emergency symptoms: Sudden total hearing loss accompanied by severe vertigo, facial weakness, or acute tinnitus - proceed to nearest emergency department immediately.
  • Pediatric considerations: Not recommended for neonatal screening without clinical indication; consent from legal guardian required.

Patient FAQ & Clinical Guidance

1. What is the CRYM gene and its role in hearing loss?

CRYM gene encodes ยต-crystallin essential for cochlear health; mutations cause autosomal dominant deafness type 40. This protein regulates thyroid hormone availability in the inner ear, and its disruption leads to progressive sensorineural hearing loss often appearing in adulthood.

2. How accurate is the NGS CRYM gene test?

NGS provides >99.9% sensitivity and specificity for CRYM variants, validated by ISO 9001:2015 standards. Every sequence variant is confirmed by orthogonal methods and interpreted according to ACMG guidelines to ensure clinical reliability.

3. What does a positive result mean for my family?

Positive CRYM result confirms hereditary deafness with 50% inheritance risk per child; genetic counseling essential. Family members can opt for cascade testing, and the information aids in early intervention and informed reproductive choices.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance:

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability.
  • DHA Facility License No: 1143.
  • DNA Labs UAE โ€“ ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name CRYM Gene Deafness, Autosomal Dominant Type 40 Genetic Test
Price (AED) 2,800
Turnaround Time 3โ€“4 Weeks
Sample Type / Matrix Peripheral Whole Blood (EDTA)
Methodology Used Next-Generation Sequencing (NGS) โ€“ Full coding exons and splice sites
ICD-10-CM Code H90.3 (Sensorineural hearing loss, bilateral)
LOINC Code 81408-0 (Hereditary hearing and deafness panel)
DHA Facility License & Laboratory Address DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians